Here you will find our latest news and updates.

January 2019 updates to website


The website has now been updated following January’s LMMG

The following drugs have been added/updated:

Cannabis-Based Medicinal Products —  For the management of patients with chronic pain

Lenvatinib NICE TA551

Liposomal cytarabine–daunorubicin NICE TA552

The following guidelines have been added/updated:

Pathway for the prevention of stroke and systemic embolism in non-valvular atrial fibrillation — Update

Asthma Treatment Guidelines for Adults (Aged 17 and over) — Replacing Asthma Guidelines for Adults and over 12s

Cannabis based medicinal products — Position statement